Novartis gets green light for production of cancer drug in Indy
The U.S. Food and Drug Administration has given approval to Switzerland-based Novartis to begin commercial manufacturing of a drug developed in Indiana at its new, $100 million plant on the west side of Indianapolis, the company said Friday.... Read More